DSXS topical

DRUG3 trials

Sponsors

Sun Pharmaceutical Industries, Inc.

Conditions

Atopic DermatitisPlaque PsoriasisScalp Psoriasis

Phase 2

An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.

CompletedNCT02932891

Sun Pharmaceutical Industries, Inc.Atopic Dermatitis

Start: 2016-08-31End: 2017-12-12Updated: 2018-12-07

An Open Label, Safety Study to Assess the Potential for Adrenal Suppression

CompletedNCT02932878

Sun Pharmaceutical Industries, Inc.Plaque Psoriasis

Start: 2016-09-02End: 2017-10-16Updated: 2018-12-06

Phase 3

Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis

CompletedNCT02933866

Sun Pharmaceutical Industries, Inc.Scalp Psoriasis

Start: 2016-03-11End: 2017-09-29Updated: 2018-12-06